Invention Grant
- Patent Title: Anti-carbamylated protein antibodies and the risk for arthritis
-
Application No.: US16120946Application Date: 2018-09-04
-
Publication No.: US10539563B2Publication Date: 2020-01-21
- Inventor: Leendert Adrianus Trouw , Reinaldus Everardus Maria Toes , Thomas Willem Johannes Huizinga , Petrus Antonius van Veelen , Anthony Cerami , Jing Shi
- Applicant: Academisch Ziekenhuis Leiden H.O.D.N. LUMC
- Applicant Address: NL Leiden
- Assignee: Academisch Ziekenhuis Leiden H.O.D.N. LUMC
- Current Assignee: Academisch Ziekenhuis Leiden H.O.D.N. LUMC
- Current Assignee Address: NL Leiden
- Agency: TraskBritt
- Priority: EP11153046 20110202; EP11182399 20110922
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/564 ; G01N33/68
Abstract:
Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. Described are means and methods for determining antibodies against homocitrulline-containing proteins or carbamylated proteins/peptides (anti-CarP) for the classification of individuals suffering from, or at risk of suffering from, arthritis.
Public/Granted literature
- US20190004044A1 ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS Public/Granted day:2019-01-03
Information query
IPC分类:
